About greedy merchants
Clinton's tweet brought down the capitalization of US biotech companies
Alexey Bogdanovsky, RIA Novosti
A tweet by US presidential candidate Hillary Clinton (Overnight, the price of a 62-year-old drug jumped to $750 a tablet from $13.50) led to a sharp collapse in the capitalization of American biotech companies on Monday, Bloomberg reported.
The index of biotech companies traded on the Nasdaq stock exchange fell by 4.7% after Clinton promised to present a plan to combat drug price increases. "Such price hikes in a special drug market are outrageous. Tomorrow I will outline a plan on how to deal with this," Clinton said in her Twitter microblog.
The candidate's reaction followed a publication in the New York Times, which stated that Turing had raised the price of the antibiotic daraprim, invented 60 years ago, from $13.5 to $750 per pill. The article also stated that the company's competitors could not obtain samples of the drug for the production of legally permitted generics. The head of Turing, Martin Shkreli, said in response to the publication that the price of the drug is still low – "it will save your life for 50 thousand dollars."
This is far from the only case of a sharp increase in antibiotic prices in recent years in the United States. So, the common antibiotic doxycycline in 2014 rose in price from $ 20 per package to 1.8 thousand. Drug prices are set by companies that own patents for their production.
In July of this year, about a hundred major oncological specialists called for combating uncontrolled price increases, which, according to them, harms patients.
In the USA, record-breaking expensive medicine, which takes up to 17% of the GDP of the world's largest economy. At the same time, international pharmaceutical companies make up to 40% of all their profits on the American market. Pharmaceutical companies often claim that high prices allow them to invest in the development of new, more effective drugs.
Portal "Eternal youth" http://vechnayamolodost.ru
23.09.2015